Endpoints News· Kyle LaHucik·· 2 小时前AI 评分42
Dren Bio 融资 3.5 亿美元，计划 2027 年将血癌药物推向市场
Dren Bio raises $350M to get blood cancer drug onto market in 2027
AI 导读
Dren Bio 完成 3.5 亿美元融资，目标是在 2027 年底前将其主打血癌药物推向市场。这家总部位于加州的药物开发商未在可获取的正文片段中披露该药物的具体名称、靶点及临床阶段数据。
正文 · 原文
Dren Bio has raised $350 million, hoping to get its lead blood cancer drug onto the market by the end of 2027, the California drug …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源：Endpoints News · endpoints.news